Bristol-Myers Squibb Aktie

Bristol-Myers Squibb für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 850501 / ISIN: US1101221083

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
31.07.2025 13:46:07

Bristol-Myers Squibb Co. Q2 Profit Decreases, But Beats Estimates

(RTTNews) - Bristol-Myers Squibb Co. (BMY) released a profit for second quarter that Decreased from last year but beat the Street estimates.

The company's earnings came in at $1.310 billion, or $0.64 per share. This compares with $1.680 billion, or $0.83 per share, last year.

Excluding items, Bristol-Myers Squibb Co. reported adjusted earnings of $2.985 billion or $1.46 per share for the period.

Analysts on average had expected the company to earn $1.10 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 0.6% to $12.269 billion from $12.201 billion last year.

Bristol-Myers Squibb Co. earnings at a glance (GAAP) :

-Earnings: $1.310 Bln. vs. $1.680 Bln. last year. -EPS: $0.64 vs. $0.83 last year. -Revenue: $12.269 Bln vs. $12.201 Bln last year.

-Guidance: Full year EPS guidance: $6.35 - $6.65 Full year revenue guidance: $46.5 - $47.5 Bln

Analysen zu Bristol-Myers Squibb Co.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Bristol-Myers Squibb Co. 38,60 -0,77% Bristol-Myers Squibb Co.